Alto Neuroscience, Inc. (ANRO)
18.36
+0.06
(+0.33%)
USD |
NYSE |
Feb 24, 10:28
Alto Neuroscience Total Assets (Quarterly) : 147.01M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 2.714B |
| Vertex Pharmaceuticals, Inc. | 26.14B |
| Fortress Biotech, Inc. | 181.41M |
| Oramed Pharmaceuticals, Inc. | 220.49M |
| Replimune Group, Inc. | 333.59M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 35.45M |
| Shareholders Equity (Quarterly) | 111.56M |
| Debt to Equity Ratio | 0.2467 |
| Current Ratio | 15.42 |
| Net Debt Paydown Yield | -3.20% |